-
OPINION: (Chelsea Clinton) The lurking threat to child survival
Emergency infectious disease outbreaks like Ebola and MERS, as serious as they are, have become black holes, sucking the necessary ingredients from health systems that could be allocated toward saving babies.
- Categories
- Health Care
- Tags
- vaccines
-
Vaccine Reminder Company Tested in Developing World
A Cornellian’s nonprofit that helps parents in developing countries remember their children’s vaccination dates with bracelets has completed an initial study in Peru and Ecuador and is moving into trials and evaluations in three countries on three continents.
- Categories
- Health Care
- Region
- Latin America
-
Viewpoint: The Ebola Vaccine We Needed
About 27,000 people in West Africa have been infected with the Ebola virus and more than 11,000 of them have died since the outbreak began last year. Many could have been saved if an effective vaccine had been available. But the world relies on drug companies to create new vaccines and medications, and they have no financial incentive to do so for diseases that mostly affect poor countries. Clearly, the world needs a better mechanism for vaccine development.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
OPINION: What ‘100 Percent Effective’ Means for That Ebola Vaccine
Lat week, the medical journal the Lancet published preliminary results on the efficacy of an Ebola vaccine in Guinea, and everybody got really excited – especially about one particular figure. The vaccine, the results suggested, was 100 percent effective at protecting against Ebola ... But that number probably means less than you think it does.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The African Startup Using Phones to Spot Counterfeit Drugs
A Ghanaian entrepreneur thinks he has the answer to Africa’s fake medicine problem.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Viewpoint: Ebola Vaccine: The Need to Act Now
One year ago West Africa was descending into chaos. As the Ebola death toll approached 1,000 for the first time ever and Liberia closed its borders, the World Health Organization declared the situation an international health emergency. Experimental drugs were cautiously put to use to try to treat those infected, but what was urgently needed to stop the spread was a vaccine. Now, 12 months on, it looks very much like we have one.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Global Vaccine-Development Fund Could Save Thousands of Lives, Billions of Dollars
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.
- Categories
- Health Care
- Tags
- vaccines
-
The New Market Builders for Health Innovation
We often criticize the fragmentation of global development into isolated silos: education, governance, agriculture, environment, humanitarian assistance, economic growth. Even within the silos, there are silos.
- Categories
- Health Care
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.